BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10640776)

  • 1. NZB mice exhibit a primary T cell defect in fetal thymic organ culture.
    Hashimoto Y; Dorshkind K; Montecino-Rodriguez E; Taguchi N; Shultz L; Gershwin ME
    J Immunol; 2000 Feb; 164(3):1569-75. PubMed ID: 10640776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired development of T lymphoid precursors from pluripotent hematopoietic stem cells in New Zealand Black mice.
    Hashimoto Y; Montecino-Rodriguez E; Gershwin ME; Dorshkind K
    J Immunol; 2002 Jan; 168(1):81-6. PubMed ID: 11751949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of defective tolerance induction in NZB mice. Evidence for a marrow pre-T cell defect.
    Laskin CA; Smathers PA; Reeves JP; Steinberg AD
    J Exp Med; 1982 Apr; 155(4):1025-36. PubMed ID: 6977614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental abnormalities of terminal deoxynucleotidyl transferase positive bone marrow cells and thymocytes in New Zealand mice: effects of prostaglandin E1.
    Whittum J; Goldschneider I; Greiner D; Zurier R
    J Immunol; 1985 Jul; 135(1):272-80. PubMed ID: 3873491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A profound deficiency in thymic progenitor cells in mice lacking Jak3.
    Baird AM; Lucas JA; Berg LJ
    J Immunol; 2000 Oct; 165(7):3680-8. PubMed ID: 11034372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice.
    Szabo P; Zhao K; Kirman I; Le Maoult J; Dyall R; Cruikshank W; Weksler ME
    J Immunol; 1998 Sep; 161(5):2248-53. PubMed ID: 9725218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early defect prethymic in bone marrow T cell progenitors in athymic nu/nu mice.
    Chatterjea-Matthes D; García-Ojeda ME; Dejbakhsh-Jones S; Jerabek L; Manz MG; Weissman IL; Strober S
    J Immunol; 2003 Aug; 171(3):1207-15. PubMed ID: 12874207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interferon-gamma on the abnormality of T cell activation in NZB mice.
    Minoda M; Funauchi M; Horiuchi A
    Clin Immunol Immunopathol; 1988 Nov; 49(2):283-91. PubMed ID: 2971491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic microenvironmental abnormalities and thymic selection in NZB.H-2bm12 mice.
    Watanabe Y; Naiki M; Wilson T; Godfrey D; Chiang BL; Boyd R; Ansari A; Gershwin ME
    J Immunol; 1993 May; 150(10):4702-12. PubMed ID: 8097760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in the capacity of bone marrow cells to differentiate in thymic organ cultures.
    Eren R; Zharhary D; Abel L; Globerson A
    Cell Immunol; 1988 Apr; 112(2):449-55. PubMed ID: 3258553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated C-met in thymic dendritic cells of New Zealand Black mice.
    Okada T; Lian ZX; Hsu T; Naiki M; Ansari AA; Robinson D; Kung HJ; Boyd R; Gershwin ME
    Dev Immunol; 2002 Mar; 9(1):29-34. PubMed ID: 12353660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an abnormal microenvironment in the thymus of New Zealand black mice.
    Dauphinée MJ; Palmer DW; Talal N
    J Immunol; 1975 Oct; 115(4):1054-9. PubMed ID: 1100721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of B lineage cells are demonstrable in long term lymphoid bone marrow cultures of New Zealand black mice.
    Yoshida S; Dorshkind K; Bearer E; Castles JJ; Ahmed A; Gershwin ME
    J Immunol; 1987 Sep; 139(5):1454-8. PubMed ID: 3497971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential role for thymic mesenchyme in early T cell development.
    Suniara RK; Jenkinson EJ; Owen JJ
    J Exp Med; 2000 Mar; 191(6):1051-6. PubMed ID: 10727466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defective NF-kappa B/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells.
    Valéro R; Baron ML; Guérin S; Béliard S; Lelouard H; Kahn-Perles B; Vialettes B; Nguyen C; Imbert J; Naquet P
    J Immunol; 2002 Jul; 169(1):185-92. PubMed ID: 12077244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited development capacity of the earliest embryonic murine thymus.
    Amagai T; Itoi M; Kondo Y
    Eur J Immunol; 1995 Mar; 25(3):757-62. PubMed ID: 7705405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.
    Jyonouchi H; Kincade PW; Good RA; Gershwin ME
    J Immunol; 1983 Nov; 131(5):2219-25. PubMed ID: 6605377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic function in NZB mice. II. Regulatory influence of a circulating thymic factor on antibody production against polyvinylpyrrolidone in NZB mice.
    Bach MA; Niaudet P
    J Immunol; 1976 Sep; 117(3):760-4. PubMed ID: 1085309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
    Christianson SW; Greiner DL; Deluca D; Leif J; Phillips NE; Hayes SM; Hayashi S; Joliat MJ; Lyons BL; Shultz LD
    J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic function in NZB mice. V. Decreased NK activity in NZB mice treated with a circulating thymic factor.
    Bardos P; Lebranchu Y; Bach MA
    Clin Immunol Immunopathol; 1982 Jun; 23(3):570-6. PubMed ID: 6889479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.